Summary

Joining leading experts at the forefront of cell biology, immunology, and autoimmunity research for a one-day event on April 30th, 2026, in New York City. The New York Academy of Sciences invites you to Autoimmunity Meets Innovation: Cell Therapies, where top researchers from academic institutions and industry professionals, as well as regulatory experts, will explore the scientific and implementation opportunities for advancing cell therapy approaches in autoimmunity. Autoimmune diseases affect a significant portion of the population, imposing substantial economic and societal burdens due to their chronic nature and profoundly impacting the quality of life for those affected.

Cutting-edge cell therapies, including CAR-T cells, CAR-Treg cells, CAR-NK cells, and CAR-MSC cells, have the potential to transform the landscape of autoimmune disease treatment. Early-stage clinical trials are already underway for a range of autoimmune conditions, such as type 1 diabetes, multiple sclerosis, myasthenia gravis, systemic lupus erythematosus (SLE), and others.

This symposium will highlight progress in the development of disruptive scientific approaches and game-changing technologies for the treatment of autoimmune diseases in both pre-clinical and clinical contexts. Don’t miss the chance to engage in dialogue and collaboration with renowned experts who will pave the way for an ecosystem that supports future scientific breakthroughs in autoimmunity research and treatment.

Sponsors

Presented By

The Biochemical Pharmacology
Discussion Group

Lead Supporters

Registration

This event is open for registration.